Sensei Biotherapeutics Inc

NASDAQ:SNSE   3:59:53 PM EDT
6.07
-0.28 (-4.41%)
Earnings Announcements

Sensei Biotherapeutics Reports Qtrly Net Loss Per Share Of $0.32

Published: 11/09/2021 14:01 GMT
Sensei Biotherapeutics Inc (SNSE) - Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights.
Sensei Biotherapeutics Inc - Expects Current Cash Balance to Fund Operations at Least Into First Half of 2024.
Sensei Biotherapeutics Inc - Qtrly Net Loss per Share $0.32.
Sensei Biotherapeutics Inc - Cash, Cash Equivalents and Marketable Securities Were $156.7 Million As of September 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.34

More details on our Analysts Page.